GE Healthcare Strengthens Life Sciences Division by Acquiring Three Businesses from Thermo Fisher Scientific
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 1 (Table of Contents)
Published: 20 Jan-2014
DOI: 10.3833/pdr.v2014.i1.2001 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
GE Healthcare has agreed to acquire Thermo Fisher Scientific’s HyClone™ cell culture business, which includes media and sera that are used to manufacture biological therapies and vaccines, as well as its gene modulation and magnetic beads businesses for approximately US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS